Labeler
Sandoz Inc NDC Codes
Sandoz Inc lists 432 finished drug products in the FDA NDC Directory under NDC labeler codes 0781, 61314.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Dexmethylphenidate Hydrochloride Extended-Release, Lisdexamfetamine dimesylate, Hyrimoz, Pomalidomide, Adalimumab, Bumetanide, Sitagliptin Phosphate, Iron Sucrose, Pyzchiva, Cyclophosphamide, Pirfenidone, Pemetrexed, Phenylephrine Hydrochloride, Dexmedetomidine Hydrochloride In 0.9% Sodium Chloride, Sugammadex
- Active ingredients
- Dexmethylphenidate hydrochloride, Adalimumab, Lisdexamfetamine dimesylate, Sitagliptin phosphate, Pomalidomide, Bumetanide, Iron sucrose, Ustekinumab, Cyclophosphamide, Pirfenidone, Pemetrexed disodium, Phenylephrine hydrochloride
- NDC labeler codes
- 0781, 61314
- Strengths (from the 100 most recently listed products)
- Sitagliptin phosphate 50 mg/1; Phenylephrine hydrochloride 10 mg/mL; Dexmedetomidine hydrochloride 4 ug/mL; Adalimumab 10 mg/.1mL; Adalimumab 80 mg/.8mL; Adalimumab 20 mg/.2mL; Fulvestrant 50 mg/mL; Adalimumab 40 mg/.4mL; Pirfenidone 267 mg/1; Acetaminophen 10 mg/mL; Dexmethylphenidate hydrochloride 25 mg/1; Dexmethylphenidate hydrochloride 30 mg/1; Dexmethylphenidate hydrochloride 35 mg/1; Dexmethylphenidate hydrochloride 40 mg/1; Dexmethylphenidate hydrochloride 10 mg/1; Dexmethylphenidate hydrochloride 5 mg/1; Dexmethylphenidate hydrochloride 15 mg/1; Dexmethylphenidate hydrochloride 20 mg/1; Pomalidomide 2 mg/1; Pomalidomide 1 mg/1
- Dosage forms
- Injection, Solution, Injection, Capsule, Tablet, Film coated, Capsule, Extended release, Tablet, Suspension/ drops, Injection, Solution, Concentrate, Solution/ drops, Kit, Injection, Powder, Lyophilized, For solution, Concentrate, Injection, Powder, For solution, Injection, Powder, Lyophilized, For suspension, Aerosol, Metered
- Routes
- Oral, Intravenous, Subcutaneous, Ophthalmic, Intravitreal, Intramuscular, Parenteral, Respiratory (Inhalation), Auricular (Otic)
- Drug classes (FDA established)
- Central Nervous System Stimulant, Tumor Necrosis Factor Blocker, Parenteral Iron Replacement, Dipeptidyl Peptidase 4 Inhibitor, Thalidomide Analog, Phosphate Binder, Loop Diuretic, Interleukin-12 Antagonist, Interleukin-23 Antagonist, Pyridone, Folate Analog Metabolic Inhibitor, alpha-1 Adrenergic Agonist, Central alpha-2 Adrenergic Agonist, Aminosalicylate, Corticosteroid, Sodium-Glucose Cotransporter 2 Inhibitor, Kinase Inhibitor, Biguanide, Microtubule Inhibitor, Serotonin-4 Receptor Agonist, RANK Ligand Inhibitor, Vascular Endothelial Growth Factor Inhibitor, alpha-Adrenergic Agonist, Estrogen Receptor Antagonist, Phenothiazine, Macrolide Antibacterial, Purine Antimetabolite, Proton Pump Inhibitor, Integrin Receptor Antagonist, Endothelin Receptor Antagonist, Barbiturate, Methylxanthine, Nonsteroidal Anti-inflammatory Drug, Platelet Aggregation Inhibitor, Nucleoside Metabolic Inhibitor, Prostaglandin Analog, beta-Adrenergic Blocker, Penicillin-class Antibacterial, beta Lactamase Inhibitor, beta2-Adrenergic Agonist, Carbonic Anhydrase Inhibitor, Fluoroquinolone Antibacterial
- HCPCS / J-code
- J1756 — Injection, iron sucrose, 1 mg, J0897 — Injection, denosumab, 1 mg, J0135 — Injection, adalimumab, 20 mg, J3357 — Injection, ustekinumab, for subcutaneous injection, 1 mg, J2778 — Injection, ranibizumab, 0.1 mg, J0131 — Injection, acetaminophen, 10 mg
- Package NDCs
- 140 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Entacapone | Entacapone 200 mg/1 | Tablet, Film coatedOral | 0781-5578 | 00781-5578-01 | — |
| Benazepril Hydrochloride and Hydrochlorothiazide | Benazepril hydrochloride 10 mg/1; Hydrochlorothiazide 12.5 mg/1 | Tablet, Film coatedOral | 0185-0325 | 00185-0325-01 | — |
| Griseofulvin | Griseofulvin 250 mg/1 | TabletOral | 0781-5514 | 00781-5514-0100781-5514-05 | — |
| Griseofulvin | Griseofulvin 500 mg/1 | TabletOral | 0781-5515 | 00781-5515-0100781-5515-05 | — |
| Difluprednate Ophthalmic | Difluprednate .5 mg/mL | EmulsionOphthalmic | 0781-6000 | 00781-6000-78 | — |
| Azelastine Hydrochloride | Azelastine hydrochloride .5 mg/mL | Solution/ dropsIntraocular | 61314-308 | 61314-0308-02 | — |
| Clindamycin in 5 Percent Dextrose | Clindamycin 6 mg/mL | Injection, SolutionIntravenous | 0781-3288 | 00781-3288-09 | — |
| Clindamycin in 5 Percent Dextrose | Clindamycin 12 mg/mL | Injection, SolutionIntravenous | 0781-3289 | 00781-3289-09 | — |
| Clindamycin in 5 Percent Dextrose | Clindamycin 18 mg/mL | Injection, SolutionIntravenous | 0781-3290 | 00781-3290-09 | — |
| Montelukast | Montelukast sodium 10 mg/1 | Tablet, Film coatedOral | 0781-5560 | 00781-5560-1300781-5560-3100781-5560-92 | — |
| cisatracurium besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | 0781-3150 | 00781-3150-95 | — |
| cisatracurium besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | 0781-3152 | 00781-3152-95 | — |
| cisatracurium besylate | Cisatracurium besylate 10 mg/mL | InjectionIntravenous | 0781-3153 | 00781-3153-95 | — |
| Cosyntropin | Cosyntropin .25 mg/mL | Injection, Powder, Lyophilized, For solutionIntravenous | 0781-3440 | 00781-3440-95 | — |
| Voriconazole | Voriconazole 10 mg/mL | Injection, Powder, Lyophilized, For solutionIntravenous | 0781-3416 | 00781-3416-94 | — |
| voriconazole | Voriconazole 50 mg/1 | Tablet, Film coatedOral | 0781-5667 | 00781-5667-0500781-5667-1000781-5667-13+1 more | — |
| voriconazole | Voriconazole 200 mg/1 | Tablet, Film coatedOral | 0781-5668 | 00781-5668-0500781-5668-1000781-5668-13+1 more | — |
| Zolpidem tartrate | Zolpidem tartrate 6.25 mg/1 | Tablet, Extended releaseOral | 0781-5315 | 00781-5315-0100781-5315-0500781-5315-31 | — |
| Zolpidem tartrate | Zolpidem tartrate 12.5 mg/1 | Tablet, Extended releaseOral | 0781-5316 | 00781-5316-0100781-5316-0500781-5316-31 | — |
| Olanzapine | Olanzapine 10 mg/2mL | Injection, Powder, For solutionIntramuscular | 0781-9105 | 00781-9105-72 | — |
| Olanzapine | Olanzapine 10 mg/2mL | Injection, Powder, For solutionIntramuscular | 0781-3159 | 00781-3159-72 | — |
| Pilocarpine Hydrochloride | Pilocarpine hydrochloride 10 mg/mL | Solution/ dropsOphthalmic | 61314-203 | 61314-0203-15 | — |
| Pilocarpine Hydrochloride | Pilocarpine hydrochloride 20 mg/mL | Solution/ dropsOphthalmic | 61314-204 | 61314-0204-15 | — |
| Pilocarpine Hydrochloride | Pilocarpine hydrochloride 40 mg/mL | Solution/ dropsOphthalmic | 61314-206 | 61314-0206-15 | — |
| Docetaxel | Docetaxel 10 mg/mL | Injection, SolutionIntravenous | 66758-050 | 66758-0050-0166758-0050-0266758-0050-03 | — |
| Durezoldifluprednate | Difluprednate .5 mg/mL | EmulsionOphthalmic | 66758-086 | 66758-0086-75 | — |
| Latanoprost | Latanoprost 50 ug/mL | SolutionOphthalmic | 61314-547 | 61314-0547-0161314-0547-03 | — |
| Piperacillin and Tazobactam | Piperacillin sodium 2 g/10mL; Tazobactam sodium .25 g/10mL | Injection, Powder, Lyophilized, For solutionIntravenous, Parenteral | 0781-3110 | 00781-3110-95 | — |
| Piperacillin and Tazobactam | Piperacillin sodium 3 g/15mL; Tazobactam sodium .375 g/15mL | Injection, Powder, Lyophilized, For solutionIntravenous, Parenteral | 0781-3113 | 00781-3113-95 | — |
| Piperacillin and Tazobactam | Piperacillin sodium 4 g/20mL; Tazobactam sodium .5 g/20mL | Injection, Powder, Lyophilized, For solutionIntravenous, Parenteral | 0781-3114 | 00781-3114-95 | — |
| Brimonidine Tartrate | Brimonidine tartrate 1.5 mg/mL | SolutionOphthalmic | 61314-144 | 61314-0144-0561314-0144-1061314-0144-15 | — |
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | 0781-3262 | 00781-3262-68 | — |
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | 0781-3256 | 00781-3256-66 | — |
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | 0781-3268 | 00781-3268-69 | — |
| Enoxaparin Sodium | Enoxaparin sodium 150 mg/mL | InjectionSubcutaneous | 0781-3298 | 00781-3298-68 | — |
| Enoxaparin Sodium | Enoxaparin sodium 150 mg/mL | InjectionSubcutaneous | 0781-3299 | 00781-3299-69 | — |
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | 0781-3238 | 00781-3238-63 | — |
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | 0781-3246 | 00781-3246-64 | — |
| tamsulosin hydrochloride | Tamsulosin hydrochloride .4 mg/1 | CapsuleOral | 0781-2076 | 00781-2076-0100781-2076-1000781-2076-92 | — |
| Amoxicillin and Clavulanate Potassium | Amoxicillin 562.5 mg/1 + 2 more ingredients | Tablet, Multilayer, Extended releaseOral | 0781-1943 | 00781-1943-3900781-1943-82 | — |
| Dorzolamide Hydrochloride and Timolol Maleate | Dorzolamide hydrochloride 20 mg/mL; Timolol maleate 5 mg/mL | SolutionOphthalmic | 61314-030 | 61314-0030-0161314-0030-02 | — |
| Ketorolac Tromethamine | Ketorolac tromethamine 5 mg/mL | SolutionOphthalmic | 61314-126 | 61314-0126-0561314-0126-10 | — |
| Tacrolimus | Tacrolimus .5 mg/1 | CapsuleOral | 0781-2102 | 00781-2102-01 | — |
| Tacrolimus | Tacrolimus 1 mg/1 | CapsuleOral | 0781-2103 | 00781-2103-01 | — |
| Tacrolimus | Tacrolimus 5 mg/1 | CapsuleOral | 0781-2104 | 00781-2104-01 | — |
| Apraclonidine | Apraclonidine hydrochloride 5.75 mg/mL | SolutionOphthalmic | 61314-665 | 61314-0665-0561314-0665-10 | — |
| Dorzolamide Hydrochloride | Dorzolamide hydrochloride 20 mg/mL | Solution/ dropsOphthalmic | 61314-019 | 61314-0019-10 | — |
| Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfatedextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate | Dextroamphetamine saccharate 3.75 mg/1 + 3 more ingredients | Capsule, Extended releaseOral | 0781-2343 | 00781-2343-01 | — |
| Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfatedextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate | Dextroamphetamine saccharate 5 mg/1 + 3 more ingredients | Capsule, Extended releaseOral | 0781-2352 | 00781-2352-01 | — |
| Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfatedextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate | Dextroamphetamine saccharate 6.25 mg/1 + 3 more ingredients | Capsule, Extended releaseOral | 0781-2368 | 00781-2368-01 | — |
Sandoz Inc: common questions
- What is Sandoz Inc's NDC labeler code?
- 0781, 61314. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Sandoz Inc?
- Med-Code's HCPCS directory matches J1756, J0897, J0135, J3357, J2778, J0131 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.